Factors influencing cancer genetic somatic mutation test ordering by cancer physician
- PMID: 33183308
- PMCID: PMC7663861
- DOI: 10.1186/s12967-020-02610-7
Factors influencing cancer genetic somatic mutation test ordering by cancer physician
Abstract
Background: Clinical whole exome sequencing was introduced in an Australian centre in 2017, as an alternative to Sanger sequencing. We aimed to identify predictors of cancer physicians' somatic mutation test ordering behaviour.
Methods: A validated instrument assessed somatic mutation test ordering, genomic confidence, perceived utility of tumour molecular profiling, and percent of patients eligible for targeted therapy. A cash incentive was included in 189/244 questionnaires which were mailed to all Queensland cancer specialists in November 2018.
Results: 110 participated (response rate 45%); 54.7% oncologists, and the remainder were surgeons, haematologists and pulmonologists. Oncologists were more likely to respond (p = 0.008), and cash incentive improved the response rate (p < 0.001). 67/102 (65.7%) of physicians ordered ≥ 5 somatic mutation tests annually. Oncologists saw 86.75 unique patients monthly and ordered 2.33 somatic mutation tests (2.2%). An average of 51/110 (46.1%) reported having little/no genomic confidence. Logistic regression identified two significant predictors of somatic mutation test ordering: being an oncologist (OR 3.557, CI 1.338-9.456; p = 0.011) and having greater confidence in interpreting somatic results (OR 5.926, CI 2.230-15.74; p < 0.0001).
Conclusions: Consistent with previous studies, the majority of cancer physicians ordered somatic mutation tests. However, the percentage of patients on whom tests were ordered was low. Almost half respondents reported low genomic confidence. Somatic mutation test ordering was higher amongst oncologists and those with increased confidence in interpreting somatic variants. It is unclear whether genomically confident individuals ordered more tests or whether ordering more tests increased genomic confidence. Educational interventions could improve confidence and enhance test ordering behaviour.
Keywords: Attitudes; Cancer physicians; Confidence; Genomic; Ordering; Somatic.
Conflict of interest statement
The authors declare that no conflict of interest exists in relation to this work.
Similar articles
-
Integrating next-generation sequencing into pediatric oncology practice: An assessment of physician confidence and understanding of clinical genomics.Cancer. 2017 Jun 15;123(12):2352-2359. doi: 10.1002/cncr.30581. Epub 2017 Feb 13. Cancer. 2017. PMID: 28192596 Free PMC article.
-
Physicians' attitudes about multiplex tumor genomic testing.J Clin Oncol. 2014 May 1;32(13):1317-23. doi: 10.1200/JCO.2013.52.4298. Epub 2014 Mar 24. J Clin Oncol. 2014. PMID: 24663044 Free PMC article.
-
Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling.J Gen Intern Med. 2011 Aug;26(8):834-40. doi: 10.1007/s11606-011-1651-7. Epub 2011 Feb 11. J Gen Intern Med. 2011. PMID: 21311998 Free PMC article.
-
Patients' and Oncologists' Knowledge and Expectations Regarding Tumor Multigene Next-Generation Sequencing: A Narrative Review.Oncologist. 2021 Aug;26(8):e1359-e1371. doi: 10.1002/onco.13783. Epub 2021 Apr 21. Oncologist. 2021. PMID: 33823080 Free PMC article. Review.
-
Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.Cancer Lett. 2013 Nov 1;340(2):270-6. doi: 10.1016/j.canlet.2012.11.002. Epub 2012 Nov 12. Cancer Lett. 2013. PMID: 23153794 Review.
Cited by
-
Queensland Genomics: an adaptive approach for integrating genomics into a public healthcare system.NPJ Genom Med. 2021 Aug 18;6(1):71. doi: 10.1038/s41525-021-00234-4. NPJ Genom Med. 2021. PMID: 34408148 Free PMC article. Review.
-
A video intervention to improve patient understanding of tumor genomic testing in patients with cancer.Cancer Med. 2024 Sep;13(17):e70095. doi: 10.1002/cam4.70095. Cancer Med. 2024. PMID: 39258462 Free PMC article.
-
Primary care provider practices, attitudes, and confidence with hereditary cancer risk assessment and testing: A mixed methods study.Genet Med. 2025 Apr;27(4):101307. doi: 10.1016/j.gim.2024.101307. Epub 2024 Oct 29. Genet Med. 2025. PMID: 39484797
-
Epistemic Beliefs: Relationship to Future Expectancies and Quality of Life in Cancer Patients.J Pain Symptom Manage. 2022 Apr;63(4):512-521. doi: 10.1016/j.jpainsymman.2021.12.017. Epub 2021 Dec 22. J Pain Symptom Manage. 2022. PMID: 34952170 Free PMC article.
-
Attitudes about pharmacogenomic testing vary by healthcare specialty.Pharmacogenomics. 2023 Jul;24(10):539-549. doi: 10.2217/pgs-2023-0039. Epub 2023 Jul 17. Pharmacogenomics. 2023. PMID: 37458095 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical